UNSPSC 51284608: Doripenem monohydrate

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B035T6NKT. European Medicines Agency schedules Doripenem hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26847. Doripenem monohydrate generally arises in the molecular formula C15H24N4O6S2.H2O. The term 'doripenem monohydrate' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule doripenem monohydrate under HS 29419000 and SITC 54139.

As of Q4 2014, DORIPENEM MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O.O.

UNSPSC 51284608 Doripenem monohydrate is a Commodity code for a specific injectable antibiotic product, though the recent state and local opportunities tagged under this code do not reflect procurement of doripenem itself. Instead, the code appears in state and local systems alongside pharmaceutical warehouse supply contracts and community health product acquisitions that include other antibiotic and emergency-response medications. State and local buyers using this code include state health departments, county health authorities, and special-purpose health districts procuring pharmaceutical products through competitive bidding, piggyback arrangements, and consortium purchasing vehicles. The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies visible in recent activity.

Recent opportunities show little direct procurement of doripenem; instead, the code tags mixed pharmaceutical supply contracts. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets via IFB, with a 12-month initial term and two renewal options. Seminole County, Florida released an IFB (posted June 30, 2026, response due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year term with one-year renewal option. Activity concentrates in Illinois and Florida, though the code's nominal scope and actual recent solicitations diverge significantly, suggesting either miscoding in the state and local systems or limited recent doripenem-specific procurement.